EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Advantage of Tolerability following Arsenic Trioxide-VTD vs VRD in newly diagnosed multiple myeloma patients: a prospective, open-label study

Xinyu Zuo, Apeng Yang, Pingping Chen, Yanhui Xie, Zhiyong Zeng, Jiexian Ma

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.110231 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Xinyu Zuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Huadong Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Arsenic Trioxide, Antineoplastic Combined Chemotherapy Protocols. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaArsenic TrioxideAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedAgedDexamethasoneProspective StudiesBortezomibThalidomideCost-Benefit AnalysisAged, 80 and overLenalidomideTreatment OutcomeAdult

Stichwörter der Autor:innen

arsenic trioxidecost-effectivenessmultiple myelomatolerabilitytreatment response

Substanzen

Arsenic TrioxideDexamethasoneBortezomibThalidomideLenalidomide

Autor:innen und Institutionen

  • Department of Hematology, Huadong Hospital, Fudan University, Shanghai, China.
  • Department of Hematology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Zitieren

APA

Zuo, X., Yang, A., Chen, P., Xie, Y., Zeng, Z., & Ma, J. (2025). Advantage of Tolerability following Arsenic Trioxide-VTD vs VRD in newly diagnosed multiple myeloma patients: a prospective, open-label study. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.110231

Vancouver

Zuo X, Yang A, Chen P, Xie Y, Zeng Z, Ma J. Advantage of Tolerability following Arsenic Trioxide-VTD vs VRD in newly diagnosed multiple myeloma patients: a prospective, open-label study. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.110231

BibTeX
@article{Zuo2025,
  author = {Zuo, Xinyu and Yang, Apeng and Chen, Pingping and Xie, Yanhui and Zeng, Zhiyong and Ma, Jiexian},
  title = {Advantage of Tolerability following Arsenic Trioxide-VTD vs VRD in newly diagnosed multiple myeloma patients: a prospective, open-label study},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.110231}
}
Kostenlos starten →